Search research articles
Contact Us
Filters
Showing results (1-10 of 83) with videos related to
Page
of 9
Sort By:
Frontiers in Neurology
|
January 6, 2011
A new frontier for headache
Stephen Silberstein
Expert Review of Clinical Pharmacology
|
June 13, 2017
AVP-825: a novel intranasal delivery system for low-dose sumatriptan powder in the treatment of acute migraine
Stephen Silberstein
Pain Practice : the Official Journal of World Institute of Pain
|
November 30, 2006
Botulinum neurotoxins: origins and basic mechanisms of action
Stephen Silberstein
Headache
|
June 15, 2016
The Management of Adults With Acute Migraine in the Emergency Department
Stephen Silberstein
Headache
|
June 1, 2013
Gastrointestinal manifestations of migraine: meeting the treatment challenges
Stephen Silberstein
Expert Opinion on Pharmacotherapy
|
August 7, 2012
MAP0004: dihydroergotamine mesylate inhalation aerosol for acute treatment of migraine
Stephen Silberstein
Archives of Neurology
|
January 16, 2008
Botulinum toxin type A for the treatment of headache: why we say yes
Avi Ashkenazi, Stephen Silberstein
Expert Opinion on Pharmacotherapy
|
August 10, 2007
Menstrual migraine: a review of hormonal causes, prophylaxis and treatment
Avi Ashkenazi, Stephen Silberstein
Expert Opinion on Pharmacotherapy
|
August 8, 2014
Menstrual migraine: an updated review on hormonal causes, prophylaxis and treatment
Stephen Silberstein, Sumit Patel
Headache
|
November 3, 2006
Central sensitization theory of migraine: clinical implications
David Dodick, Stephen Silberstein
Page
of 9
Search research articles
Search
Showing results (1-10 of 83) with videos related to
Sort By:
Page
of 9
Frontiers in Neurology
|
January 6, 2011
A new frontier for headache
Stephen Silberstein
Expert Review of Clinical Pharmacology
|
June 13, 2017
AVP-825: a novel intranasal delivery system for low-dose sumatriptan powder in the treatment of acute migraine
Stephen Silberstein
Pain Practice : the Official Journal of World Institute of Pain
|
November 30, 2006
Botulinum neurotoxins: origins and basic mechanisms of action
Stephen Silberstein
Headache
|
June 15, 2016
The Management of Adults With Acute Migraine in the Emergency Department
Stephen Silberstein
Headache
|
June 1, 2013
Gastrointestinal manifestations of migraine: meeting the treatment challenges
Stephen Silberstein
Expert Opinion on Pharmacotherapy
|
August 7, 2012
MAP0004: dihydroergotamine mesylate inhalation aerosol for acute treatment of migraine
Stephen Silberstein
Archives of Neurology
|
January 16, 2008
Botulinum toxin type A for the treatment of headache: why we say yes
Avi Ashkenazi, Stephen Silberstein
Expert Opinion on Pharmacotherapy
|
August 10, 2007
Menstrual migraine: a review of hormonal causes, prophylaxis and treatment
Avi Ashkenazi, Stephen Silberstein
Expert Opinion on Pharmacotherapy
|
August 8, 2014
Menstrual migraine: an updated review on hormonal causes, prophylaxis and treatment
Stephen Silberstein, Sumit Patel
Headache
|
November 3, 2006
Central sensitization theory of migraine: clinical implications
David Dodick, Stephen Silberstein
Page
of 9